Skip to main content
NCBI home page
Molecular Neurodegeneration logoLink to Molecular Neurodegeneration
. 2016 Feb 8;11:15. doi: 10.1186/s13024-016-0080-9

Erratum to: ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis

Sighild Lemarchant 1,✉, Yuriy Pomeshchik 1, Iurii Kidin 1, Virve Kärkkäinen 1, Piia Valonen 1, Sarka Lehtonen 1, Gundars Goldsteins 1, Tarja Malm 1, Katja Kanninen 1, Jari Koistinaho 1
PMCID: PMC4745151  PMID: 26858022

Unfortunately, after publication of this article [1], an error was discovered in Fig. 12 (Fig. 1 here) that was introduced during the Production process. The corrected figure can be seen below and the original article has also been updated to reflect this change.

Fig. 1.

Fig. 1

Open in a new tab

Gender similarities and differences in the effect of ADAMTS-4 treatment on ALS. a Schematic representation of ADAMTS-4 treatment promoting the decline of NGF production and ALS-induced perineuronal net degradation which contribute to the degeneration and even death of motoneurons in the ventral horn of the lumbar spinal cord of SOD1G93A mice. b A table describing the similarities and differences observed in behavioral and anatomical effects of ADAMTS-4 treatment in SOD1G93A male and female mice

Footnotes

The online version of the original article can be found under doi:10.1186/s13024-016-0078-3.

Reference

  • 1.Sighild Lemarchant, Yuriy Pomeshchik, Iurii Kidin, Virve Kärkkäinen, Piia Valonen, Sarka Lehtonen, et al. ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis. Mol Neurodegener. 2016;11:10 doi:10.1186/s13024-016-0078-3 [DOI] [PMC free article] [PubMed]

Articles from Molecular Neurodegeneration are provided here courtesy of BMC

RESOURCES